[1]
“The Expanding Role of Dapagliflozin Beyond the Glucose-lowering Effec”, IJCP, vol. 33, no. 3, pp. 21–28, Aug. 2022, Accessed: Apr. 24, 2025. [Online]. Available: https://ojs.ijcp.in/index.php/IJCP/article/view/247